Sequence information
Variant position: 373 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 631 The length of the canonical sequence.
Location on the sequence:
PWLPAEALRTLRIGGFYALS
P YPGLRLISLNMNFCSRENFW
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human PWLPAEALRTLRIGGFYALSP YPGLRLISLNMNFCSRENFW
Mouse PWLPADALHTLRIGGFYALTP RPGLRLISLNMNFCSRENFW
Bovine PWLPAEALRTLRIGGFYALSP RPGLRLISLNMNFCSRENFW
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
Chain
47 – 631
Sphingomyelin phosphodiesterase
Alternative sequence
365 – 420
Missing. In isoform 3.
Alternative sequence
365 – 376
IGGFYALSPYPG -> YLSSVETQEGKR. In isoform 2.
Beta strand
369 – 374
Literature citations
Seven novel Acid sphingomyelinase gene mutations in Niemann-Pick type A and B patients.
Sikora J.; Pavluu-Pereira H.; Elleder M.; Roelofs H.; Wevers R.A.;
Ann. Hum. Genet. 67:63-70(2003)
Cited for: VARIANTS NPDA ARG-250; TYR-321; SER-465; LEU-477 AND HIS-539; VARIANTS NPDB SER-373 AND ARG-610 DEL;
Acid sphingomyelinase (Asm) deficiency patients in The Netherlands and Belgium: disease spectrum and natural course in attenuated patients.
Hollak C.E.; de Sonnaville E.S.; Cassiman D.; Linthorst G.E.; Groener J.E.; Morava E.; Wevers R.A.; Mannens M.; Aerts J.M.; Meersseman W.; Akkerman E.; Niezen-Koning K.E.; Mulder M.F.; Visser G.; Wijburg F.A.; Lefeber D.; Poorthuis B.J.;
Mol. Genet. Metab. 107:526-533(2012)
Cited for: VARIANTS NPDB HIS-91; PRO-105; PRO-163; CYS-230; SER-373; PRO-551 AND ARG-610 DEL; VARIANTS NPDA ARG-250; SER-465; LEU-477 AND HIS-539;
Disclaimer:
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.